Form 4: Nuvalent CLO Exercises Options, Sells Shares

Nuvalent's Chief Legal Officer, Deborah Ann Miller, exercised stock options and subsequently sold an equivalent number of shares under a pre-arranged 10b5-1 trading plan.

Summary

• Deborah Ann Miller, Nuvalent, Inc.'s Chief Legal Officer, engaged in transactions involving Class A Common Stock on February 26, 2026.
• Miller exercised 5,500 stock options at an exercise price of $6.89 per share.
• Concurrently, Miller sold a total of 5,500 Class A Common Stock shares in multiple transactions.
• The sales included 2,698 shares at a weighted average price of $102.64 (ranging from $101.96 to $102.95).
• An additional 2,602 shares were sold at a weighted average price of $103.41 (ranging from $102.96 to $103.95).
• A further 200 shares were sold at a price of $103.96.
• All transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
• Following these transactions, Miller beneficially owns 59,634 shares of Class A Common Stock directly and 89,108 derivative stock options directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine insider transaction for compensation and liquidity management, which is not indicative of a significant positive or negative shift in company prospects.

Positives

• The option exercise price of $6.89 is significantly lower than the sale prices (ranging from $101.96 to $103.96), indicating a substantial profit for the insider on these transactions.
• The transactions were executed under a Rule 10b5-1 trading plan, suggesting pre-planned sales for liquidity or diversification rather than reactive selling based on new, non-public information.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived negatively by the market, although these transactions appear to be a routine exercise-and-sell for compensation.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• Transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving the exercise of vested stock options and subsequent sales under a Rule 10b5-1 plan, are a common practice for executive compensation and personal financial planning. These transactions typically do not reflect a change in the company's operational performance or strategic outlook, aligning with standard industry practices for executive liquidity.

Stakeholder Impact

• Shareholders: The transactions represent a routine part of executive compensation and liquidity management, with minimal direct impact on the broader shareholder base beyond the standard implications of insider activity.

Key Dates

Recommendation

This Form 4 details a routine insider transaction involving the exercise of vested stock options and the subsequent sale of shares under a pre-arranged 10b5-1 trading plan. Such transactions are common for executive compensation and personal liquidity and typically do not reflect a change in the insider's view of the company's long-term prospects. Therefore, it provides no new fundamental information to alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

Nuvalent, NUVL, Insider Trading, Form 4, Stock Options, Share Sale, 10b5-1 Plan, Chief Legal Officer, Deborah Ann Miller